How to Choose the Right Model Animal

• Begin by defining the primary question as mechanistic, pharmacologic, toxicologic, surgical, behavioral, or translational, because different objectives require different levels of disease resemblance and physiological complexity^[3][4].

• Next, perform a structured literature review to identify candidate models, prior effect sizes, known limitations, sex and age considerations, genetic background effects, available assays, welfare concerns, and evidence of translation to humans^[1][5][7].

• Then, apply a model-selection matrix that scores each candidate for human phenotype similarity, mechanism similarity, endpoint measurability, reproducibility, feasibility, genetic or pharmacologic tractability, clinical relevance, and 3Rs impact^[1][2][8].

• If the literature is insufficient, conduct a small pilot focused on feasibility and variance estimation rather than hypothesis confirmation, then use those data to design a properly powered confirmatory experiment^[9][11].

• After model selection, implement randomization, blinding, allocation concealment, prespecified exclusion criteria, sex and age justification, welfare monitoring, and ARRIVE-compliant reporting^[6][7][9].

• Finally, validate translational relevance by comparing animal endpoints with human pathology, biomarkers, clinical exposures, or patient-derived experimental systems before making claims about human disease or therapeutic prediction^[3][4][10].

Objective 1: Define the biological and translational requirements.

• Research approach: convert the research question into required disease features and measurable endpoints.
• Experimental model: no animal is selected yet; candidate species and models are compared on paper.
• Experimental groups: candidate model list, including non-animal alternatives, small-animal models, and large-animal models where justified.
• Key techniques: systematic literature review, phenotype mapping, endpoint mapping, and harm-benefit assessment.
• Detection indices: human phenotype match, mechanism match, available assays, feasibility, welfare burden, and translational relevance.
• Expected results: a ranked shortlist of models.
• Interpretation: the best candidate is the lowest-burden model that can answer the primary biological question^[1][3][8].

Objective 2: Compare candidate animal models experimentally.

• Research approach: run a pilot or feasibility comparison only if published evidence is insufficient to choose among models.
• Experimental model: two or more candidate species, strains, ages, sexes, or disease-induction methods.
• Experimental groups: healthy control, disease model A, disease model B, and reference comparator when available.
• Key techniques: phenotype scoring, histology, imaging, molecular assays, behavioral or physiological testing, and welfare monitoring.
• Detection indices: phenotype penetrance, variability, severity, mortality, welfare score, assay compatibility, and concordance with human clinical features.
• Expected results: one model should show the strongest combination of disease relevance, reproducibility, measurable endpoints, and acceptable welfare burden.
• Interpretation: a model with high validity and lower harm should be preferred over a familiar but poorly justified model^[1][2][3].

Objective 3: Validate internal validity and reproducibility.

• Research approach: test whether the selected model can produce reliable data under rigorous design.
• Experimental model: selected candidate model.
• Experimental groups: control, disease model, intervention or positive-control group if justified, and sham or vehicle controls when relevant.
• Key techniques: randomization, allocation concealment, blinded outcome assessment, prespecified endpoints, power calculation, and ARRIVE-compliant reporting.
• Detection indices: effect size, variance, attrition, mortality, endpoint reliability, and blinded reproducibility.
• Expected results: the model should generate stable, interpretable outcomes with transparent animal flow and prespecified analysis.
• Interpretation: a biologically plausible model is not acceptable unless it also has adequate internal validity^[6][7][9].

Objective 4: Validate external and translational relevance.

• Research approach: compare animal results with independent evidence from humans or human-relevant systems.
• Experimental model: selected animal model plus patient data, clinical specimens, organoids, ex vivo tissue, or published clinical datasets.
• Experimental groups: animal control, animal disease model, human control sample, and human disease sample.
• Key techniques: cross-species transcriptomics, histopathology comparison, biomarker validation, pharmacokinetic/pharmacodynamic assessment, and endpoint alignment.
• Detection indices: shared biomarkers, conserved mechanisms, matching disease trajectory, clinically relevant exposure, and comparable therapeutic direction.
• Expected results: the selected model should reproduce the specific human-relevant mechanism or endpoint needed for the study.
• Interpretation: discordance does not automatically invalidate the model, but it limits the claims that can be made from it^[3][4][10].

Objective 1

• Produce a transparent justification for why an animal model is needed and why lower-complexity alternatives are insufficient; this supports ethical and scientific justification^[1][8].

Objective 2

• Identify the candidate model that best balances disease relevance, assay feasibility, reproducibility, and animal welfare; failure to identify a clearly suitable model should lead to redesign or use of alternative systems^[1][2][3].

Objective 3

• Show that the selected model can produce reliable data under rigorous experimental controls; high variability, attrition, or unclear endpoints would argue against using the model for confirmatory work^[6][7][9].

Objective 4

• Show whether animal outcomes align with human-relevant mechanisms or biomarkers; strong alignment supports translational use, whereas weak alignment restricts the model to mechanistic or exploratory claims^[3][4][10].

1: model selection may be based on availability, tradition, or local expertise rather than predictive value.

Alternative: require a written model-selection matrix comparing candidate models against the research question and human phenotype^[1].

2: a model may reproduce visible disease features but not the underlying human mechanism.

Alternative: distinguish face validity from construct validity and select the model according to the specific experimental objective^[3][4].

3: results may be biased by poor design, including lack of randomization, blinding, sample-size calculation, or transparent reporting.

Alternative: follow ARRIVE guidance and internal-validity recommendations before starting confirmatory animal work^[6][7][9].

4: sex, age, strain, microbiome, and environment may change phenotype expression or treatment response.

Alternative: justify biological variables prospectively and include relevant variation when the research question requires generalizability^[7][12].

5: animal findings may not translate to humans even when internally valid.

Alternative: validate major findings in human tissue, organoids, ex vivo systems, clinical datasets, or cross-species biomarker comparisons before claiming clinical relevance^[3][4][10].